Company intelligence / Profile preview

p53 Invest

Würzburg, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

p53 Invest is a German-based investment firm specifically focused on the life sciences, biotechnology, and healthcare sectors. The company provides capital and strategic support to early-stage and growth-oriented biotech firms, often focusing on innovative therapeutic approaches and medical technologies. By leveraging a deep understanding of the regulatory and clinical landscape, p53 Invest aims to bridge the gap between scientific discovery and commercial success. Their portfolio typically includes companies working on oncology, rare diseases, and advanced diagnostic tools.

Industry: Investors

Beyond the preview

Go deeper on p53 Invest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on p53 Invest.

Explore the full profile